• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型化学制剂阿比朵尔:其在流感流行期间的预防效果

[The new chemical preparation arbidol: its prophylactic efficacy during influenza epidemics].

作者信息

Gagarinova V M, Ignat'eva G S, Sinitskaia L V, Ivanova A M, Rodina M A, Tur'eva A V

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 1993 Sep-Oct(5):40-3.

PMID:8067142
Abstract

In four controlled observations on the organized groups of students and industrial workers during the epidemics of influenza A in 1988-1989 Arbidol, a new chemopreparation, was found to be well tolerated and to produce a pronounced prophylactic effect when administered in a dose of 0.2 g (2 tablets of 0.1 g) daily for 10-18 days. After the 18-day prophylactic course of Arbidol the induction of serum interferon was found.

摘要

在1988 - 1989年甲型流感流行期间,对学生和产业工人的有组织群体进行了四项对照观察,发现一种新的化学制剂阿比朵尔耐受性良好,当每日服用0.2克(2片0.1克),持续10 - 18天时可产生显著的预防效果。在阿比朵尔进行18天的预防疗程后,发现血清干扰素被诱导产生。

相似文献

1
[The new chemical preparation arbidol: its prophylactic efficacy during influenza epidemics].新型化学制剂阿比朵尔:其在流感流行期间的预防效果
Zh Mikrobiol Epidemiol Immunobiol. 1993 Sep-Oct(5):40-3.
2
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).乌米芬ovir在流感和急性呼吸道病毒感染中的临床疗效(ARBITR研究)
Ter Arkh. 2019 Mar 30;91(3):56-63. doi: 10.26442/00403660.2019.03.000127.
3
[The protective action of arbidol during a rise in respiratory diseases in 1990].
Vopr Virusol. 1991 Sep-Oct;36(5):380-1.
4
[The biological activity of saparal in an influenzal infection].[沙帕拉尔在流感感染中的生物活性]
Vopr Virusol. 1994 May-Jun;39(3):131-4.
5
[Antimetastatic effects of the new antiviral agent arbidol].新型抗病毒药物阿比朵尔的抗转移作用
Biull Eksp Biol Med. 1994 Jul;118(7):80-1.
6
[Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A].[各种流感病毒株对阿比多尔的敏感性。阿比多尔与不同抗病毒药物联合使用对甲型流感病毒复制的影响]
Ter Arkh. 2005;77(8):84-8.
7
[Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].[俄罗斯抗流感药物在细胞培养和动物模型中的抗病毒活性研究]
Vopr Virusol. 2010 May-Jun;55(3):19-27.
8
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR].阿比朵尔(乌米芬诺)治疗成人流感的临床疗效:多中心双盲随机安慰剂对照研究ARBITR的初步结果
Ter Arkh. 2015;87(1):88-96. doi: 10.17116/terarkh201587188-96.
9
[Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season].[2004 - 2005年季节在俄罗斯引起流行性发病率上升的流感病毒对金刚烷胺和阿比朵尔的敏感性]
Vopr Virusol. 2007 Mar-Apr;52(2):24-9.
10
[Efficacy and safety of arbidol in treatment of naturally acquired influenza].阿比朵尔治疗自然感染流感的疗效与安全性
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):289-93.

引用本文的文献

1
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".撤回并重新发布自:“流感抗病毒药物研发的现状:临床试验药物和已获许可药物”。
mBio. 2024 May 8;15(5):e0017524. doi: 10.1128/mbio.00175-24. Epub 2024 Mar 29.
2
Arbidol: The current demand, strategies, and antiviral mechanisms.阿比多尔:当前需求、策略和抗病毒机制。
Immun Inflamm Dis. 2023 Aug;11(8):e984. doi: 10.1002/iid3.984.
3
Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients.
抗病毒药物阿比朵尔与降低新冠病毒感染患者的院内死亡率有关。
Cardiol Discov. 2021 Dec 3;1(1):37-43. doi: 10.1097/CD9.0000000000000014. eCollection 2021 Mar.
4
Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein.基于 S 蛋白 S2 亚基的阿比多尔衍生物及其他 SARS-CoV-2 融合抑制剂的结构-活性关系建模。
J Chem Inf Model. 2021 Dec 27;61(12):5906-5922. doi: 10.1021/acs.jcim.1c01061. Epub 2021 Dec 13.
5
Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure.流感血凝素的结构生物学:一场永恒的冒险。
Viruses. 2020 Sep 22;12(9):1053. doi: 10.3390/v12091053.
6
Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application.抗氧化治疗是否对新冠病毒治疗有效?一种应用该疗法的算法。
Medicina (Kaunas). 2020 Jul 31;56(8):386. doi: 10.3390/medicina56080386.
7
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals.阿比多尔预防卫生专业人员 COVID-19 的有效性。
Front Public Health. 2020 May 29;8:249. doi: 10.3389/fpubh.2020.00249. eCollection 2020.
8
Current and Novel Approaches in Influenza Management.流感管理中的当前及新方法。
Vaccines (Basel). 2019 Jun 18;7(2):53. doi: 10.3390/vaccines7020053.
9
Current Strategies for Inhibition of Chikungunya Infection.当前抑制基孔肯雅热感染的策略。
Viruses. 2018 May 3;10(5):235. doi: 10.3390/v10050235.
10
Iminosugars: Promising therapeutics for influenza infection.亚氨基糖:流感感染的有前景的治疗药物。
Crit Rev Microbiol. 2017 Sep;43(5):521-545. doi: 10.1080/1040841X.2016.1242868. Epub 2016 Dec 8.